Endo International plc completes global restructuring

Goodmans LLP acted as Canadian legal counsel to the Endo Group (or the “Company”) in connection with its restructuring initiatives, transaction matters, negotiated resolutions with Canadian stakeholders, and the Canadian recognition proceedings.

Endo implemented its chapter 11 plan of reorganization (the “Plan”) and completed its global restructuring in April 2024. The Plan restructured funded debt obligations of US$8.15 billion and provided more than US$600 million in recoveries for unsecured creditors. The Plan was granted recognition in the Canadian proceedings, which was an important forum for the negotiation and determination of issues relating to Canadian stakeholders.

Endo, the ultimate parent of the Company’s speciality pharmaceutical business, was an Irish company that traded on NASDAQ. Paladin, the Company’s Canadian operating company, generated substantially all of the Company’s international revenue outside of the United States.